GL1X · GenesisL1 explorer

Research workbench

Nucleotide-free crystal structure of nucleotide-binding domain 1 from human MRP1 supports a general-base catalysis mechanism for ATP hydrolysis.

Analyse Nucleotide-free crystal structure of nucleotide-binding domain 1 from human… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4C3Z
Type
protein
Length
231 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Multidrug resistance-associated protein 1
UniProt
P33527
Ligands
SO4
Pockets
1 · best druggability 0.51

Structure

x-ray diffraction · 1 distinct chain · 32% helix, 28% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMultidrug resistance-associated protein 1protein23132% helix, 28% strandP33527

Ligands and binding sites

  • SO4 · Sulfate ion · ion · 6 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1970.510.8322empty

Compared structures

  • 4C3Z · Nucleotide-free crystal structure of nucleotide-binding domain 1 from human MRP1 supports… · the same entry in another collection · chain A against A, TM-score 1.00
  • P33527 · AlphaFold monomer V2.0 prediction for multidrug resistance-associated protein 1 (P33527) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.